stella
beta
Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma — Stella
Recruiting
Back to Cutaneous Melanoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Canada
UHN- Princess Margaret Cancer Center, Toronto, Ontario
View full record on ClinicalTrials.gov